Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.010
+0.080 (2.04%)
Oct 28, 2026, 1:29 PM EDT - Market open
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $515.82 thousand as of October 28, 2026. It is the 50,349th most valuable company in the world and the 6,924th biggest in the United States. Its market cap has decreased by 88.42% in one year.
Market Cap
515.82K
Enterprise Value
-3.77M
1-Year Change
-88.42%
Global Rank
Country Rank
#6,924 United States
Category
ChartMarket Cap Chart
Since March 17, 2022, Biodexa Pharmaceuticals's market cap has decreased from $13.70M to $515.82K, a decrease of -96.24%. That is a compound annual growth rate of -50.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 474.66K | -75.07% |
| Dec 31, 2025 | 1.90M | -19.06% |
| Dec 31, 2024 | 2.35M | -66.37% |
| Dec 29, 2023 | 6.99M | 121.92% |
| Dec 30, 2022 | 3.15M | -77.00% |
| Mar 17, 2022 | 13.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 4.33M |
| NeuroSense Therapeutics | 4.31M |
| Liminatus Pharma | 4.24M |
| Jupiter Neurosciences | 3.77M |
| PharmaCyte Biotech | 3.76M |
| KALA BIO | 3.60M |
| Addex Therapeutics | 3.31M |
| Eocene | 3.28M |